Rejuran vs Juvelook vs exosome: evidence-graded guide

Key takeaways

If you're weighing rejuran vs juvelook vs exosome for your own skin here in Canada, here's the short version before we get into the details.

Key takeaways

• Rejuran: salmon PDRN that repairs skin — the best-evidenced of the three.

• Juvelook: PDLLA collagen microspheres in an HA carrier, not plain HA.

• Exosomes: 30-150 nm vesicles whose skin claims rest on theory, not data.

What each treatment is actually made of

These three get sold side by side, but the top guides can't even agree on what Juvelook is. Fix that first. You can't compare treatments you can't correctly name.

Start with Juvelook, because that's where the ranking pages fall apart. Its active isn't hyaluronic acid, and it isn't polynucleotides. Juvelook is a hybrid biostimulator: poly-D,L-lactic acid (PDLLA) microspheres suspended in a hyaluronic acid (HA) carrier. The HA gives same-day softening. The PDLLA sets off your own fibroblasts to build collagen over roughly six to twelve weeks. Clinic and study sources describe it the same way, and a 2025 paper in Plastic and Reconstructive Surgery – Global Open tested topical PDLLA (Juvelook) for facial pore reduction and skin-texture improvement.

Yet Beverly Wilshire's guide calls Juvelook "HA-based," and Fundamental Aesthetic Clinic calls it a "polynucleotides" treatment. Those are two different molecules and two different mechanisms, and both are wrong for a collagen biostimulator. Simple rule: if a page can't name the ingredient, don't trust its verdict.

Rejuran is the opposite of a filler. It uses salmon-derived PDRN — polynucleotides — to repair and regenerate skin from within rather than add volume. It comes in targeted versions, including Healer (the original) and S (aimed at acne scars).

Exosomes are the least settled of the three. They're membrane-bound extracellular vesicles, about 30 to 150 nanometres across, marketed in aesthetics as stem-cell-derived nanovesicles that carry regenerative signals. That's a real definition from cell biology. But a definition is not a skin result, and that gap matters later.

One honest caveat: this correction leans on clinic and study pages, not a manufacturer monograph or a Korean MFDS product listing. A primary listing would make it airtight. That source is still pending.

Rejuran vs Juvelook vs exosome, side by side

• Treatment: Rejuran / What it's made of: Salmon-derived PDRN (polynucleotides) / How it works: Repairs and regenerates skin; does not add volume / Marketed duration: ~6-12 months / Downtime: Minimal / Evidence tier: Peer-reviewed PDRN literature / Best for: Texture and acne-scar repair (S variant)

• Treatment: Juvelook / What it's made of: PDLLA microspheres in an HA carrier / How it works: HA softens same day; PDLLA builds collagen over ~6-12 weeks / Marketed duration: ~12-18 months / Downtime: Minimal / Evidence tier: One PMC-indexed pore/texture study / Best for: Firmness plus same-day softening

• Treatment: Exosomes / What it's made of: 30-150 nm extracellular vesicles (marketed as stem-cell-derived) / How it works: Cell-signalling / Marketed duration: ~3-6 months / Downtime: Minimal / Evidence tier: Cell-signalling theory + marketing label / Best for: Hardest to match on evidence

Read the duration and downtime cells as marketed claims, not verified outcomes. The ranking set frames all three as minimal-downtime, and that's a clinic claim too, not a measured result. The exosome duration is the shortest of the three and the least backed by evidence.

How strong the evidence really is for each

Grade the claims, not the adjectives. All three read as "advanced" and "rejuvenating" on the selling pages. That tells you nothing.

Rejuran sits on the firmest ground. PDRN and polynucleotide use in aesthetic medicine has peer-reviewed literature behind it, and its regenerate-don't-fill mechanism is described consistently across sources.

Juvelook is mid-tier and improving. Its composition is well-corroborated, and that 2025 PMC-indexed study supports pore reduction and texture improvement with PDLLA. That's one focused study, though, not a deep stack of trials. Real support, not overwhelming proof.

Exosomes are the weakest, and it isn't close. The sources that exist describe vesicle biology and drug delivery — what an exosome is and how it ferries cargo between cells — not what it does to aging skin in a trial. The "4th Generation Skin Booster" line you'll see everywhere is a marketing label, not evidence.

A word on "more evidence": it isn't the same as "right for you." A well-studied treatment can still be the wrong match for your goal. That's the next question.

Which one matches your skin goal

If your concern is rough texture or acne scarring, Rejuran is the natural first ask. There's an S formulation built specifically for scars, so it's worth naming by variant when you book.

If you want firmness with a little same-day softening, Juvelook fits. The HA smooths things right away while the PDLLA builds collagen over the following weeks.

If your real problem is lost volume — flat cheeks, a deflated look — none of these three is your answer. Rejuran explicitly doesn't add volume. That's a filler's job, not a regenerator's, and no amount of PDRN changes it.

Here's where each one loses. Rejuran won't plump. Juvelook makes you wait weeks for the collagen payoff, so it's poor if you need something visible tomorrow. Exosomes are the hardest to recommend for any single goal, because the evidence doesn't yet point at one.

Skin-concern decision flow: acne scars or rough texture → Rejuran (S variant); firmness + same-day softening → Juvelook; lost volume → not these three; unproven regenerative support → exosomes (weakest evidence).

How long each lasts and what upkeep looks like

Duration shapes cost over time more than the sticker on any one session. The same ranking table lists Rejuran at roughly 6-12 months and Juvelook at roughly 12-18 months, with exosomes shortest at about 3-6 months.

Juvelook's longer number comes with a longer commitment. A typical course runs about three sessions spaced roughly a month apart, and the collagen effect builds over weeks rather than landing on day one. So you're paying for more sessions up front and waiting longer to see the full result.

Rejuran's shorter window means more frequent top-ups if you want to hold the effect. All three are marketed as minimal downtime, which is convenient, but remember every one of these figures is a marketing claim, not a guaranteed outcome you can hold a clinic to.

What's actually available — and what it costs — in Canada

This is the part every Korea- and Singapore-based guide skips for a Toronto reader.

Take Juvelook's regulatory story as the warning. It's MFDS-approved in Korea and not FDA-approved in the United States. Useful context, but neither of those is Canada's regulator. Foreign approval status is not Health Canada status, and it's a mistake to read one as the other.

What actually matters for you is whether each treatment is cleared by Health Canada and offered by a licensed clinic near you. I'll be straight about the gap here: I don't have a confirmed Health Canada availability status for Rejuran, Juvelook, or exosome injectables in hand, and I won't quote a Canadian dollar price I can't source. You'll see Korean-won figures on some pages — those mean nothing for a booking in Ontario, so don't anchor on them.

Instead, treat availability and price as questions to ask, not numbers to trust off a blog. When you call a clinic, ask what's cleared for use in Canada, what they charge per session in Canadian dollars, and — for exosomes especially — how the product is sourced and standardised, since that space is still unsettled.

The exosome caveat no selling clinic mentions

Here's the downside no page selling exosomes will put in writing: the evidence behind them describes biology, not skin outcomes. The available sources cover what extracellular vesicles are and how they deliver cargo. They don't show measured improvement in wrinkles, texture, or scarring from an injectable in a controlled trial. The "4th Generation Skin Booster" phrase is a label, not a result.

That's not a reason to write exosomes off. Vesicle biology is a genuinely active research area, and the skin claims may well prove out. The honest position is "promising but unproven and unstandardised for skin," not "avoid" — and not the confident hype you'll read elsewhere either.

What to ask your clinic

A page can narrow your options and sharpen your questions. It can't assess your skin. So walk in with specifics.

• For texture or acne scarring, ask whether Rejuran — and the S variant — fits your case.

• For firmness with early softening, ask about Juvelook's session course and how long until you'd see the collagen effect.

• For exosomes, ask what skin-outcome evidence and what Health Canada status the clinic can actually show you, and how the product is sourced.

The final call needs an in-person skin assessment, which is exactly what a consult is for. If you'd like that individualised answer, book a consult to have your skin assessed — no pressure, just a starting point. It also helps to read more on collagen-stimulation treatments in Toronto and acne-scar treatment options in Toronto before you go.

How we graded this, and where it's thin

We judged all three on the same criteria: what they're made of, how strong the evidence is, what skin goal each fits, how long each lasts, downtime, and Canadian availability. Composition and mechanism come from clinic and study sources; the Juvelook correction rests on those plus a 2025 pore-and-texture study, not a manufacturer monograph.

The honest limits: there's no confirmed Health Canada status or Canadian pricing in this write-up, no exosome skin-outcome trial to grade, and no first-hand before-and-after results here. This is general information to help you ask better questions — not medical advice, and not a diagnosis of what your skin needs.